Inari Medical Financials
NARI Stock | USD 79.55 0.15 0.19% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 3.37 | 3.55 |
|
|
The essential information of the day-to-day investment outlook for Inari Medical includes many different criteria found on its balance sheet. An individual investor should monitor Inari Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Inari Medical.
Net Income |
|
Inari | Select Account or Indicator |
Inari Medical Earnings Geography
Inari Medical Stock Summary
Inari Medical competes with Outset Medical, Legend Biotech, and Progyny. Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US45332Y1091 |
CUSIP | 45332Y109 |
Location | California; U.S.A |
Business Address | 6001 Oak Canyon, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.inarimedical.com |
Phone | 877 923 4747 |
Currency | USD - US Dollar |
Inari Medical Key Financial Ratios
Return On Equity | -0.18 | ||||
Profit Margin | (0.14) % | ||||
Operating Margin | (0.04) % | ||||
Price To Sales | 8.11 X | ||||
Revenue | 493.63 M |
Inari Medical Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 214.1M | 311.5M | 504.2M | 674.2M | 775.4M | 814.1M | |
Other Current Liab | 10.8M | 34.4M | 45.9M | 64.1M | 73.7M | 77.4M | |
Net Tangible Assets | (39.1M) | 200.3M | 239.2M | 417.0M | 479.6M | 503.5M | |
Net Debt | (114.2M) | (63.5M) | (27.9M) | (6.6M) | (7.5M) | (7.9M) | |
Retained Earnings | (27.4M) | (17.6M) | (46.9M) | (48.5M) | (43.6M) | (45.8M) | |
Accounts Payable | 3.0M | 6.5M | 7.7M | 10.6M | 12.2M | 12.8M | |
Cash | 114.2M | 92.8M | 60.2M | 38.6M | 44.4M | 64.4M | |
Other Assets | 1.8M | 921K | 981K | 589K | 677.4K | 949.3K | |
Net Receivables | 28.0M | 42.4M | 58.6M | 70.1M | 80.6M | 84.7M | |
Inventory | 10.6M | 21.1M | 32.6M | 42.9M | 49.3M | 51.8M | |
Other Current Assets | 2.9M | 11.0M | 10.6M | 7.1M | 8.2M | 6.0M | |
Total Liab | 13.8M | 72.3M | 87.2M | 209.3M | 240.7M | 252.8M | |
Net Invested Capital | 200.3M | 239.2M | 417.0M | 464.9M | 534.6M | 561.4M | |
Total Current Assets | 205.7M | 245.2M | 422.9M | 235.6M | 270.9M | 215.4M | |
Capital Stock | 49K | 50K | 54K | 58K | 66.7K | 41.1K | |
Net Working Capital | 191.8M | 202.7M | 366.7M | 159.2M | 183.1M | 178.7M | |
Common Stock | 49K | 50K | 54K | 58K | 66.7K | 41.1K |
Inari Medical Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Net Interest Income | (651K) | (141K) | 1.6M | 15.4M | 17.7M | 18.6M | |
Interest Income | 484K | 154K | 1.9M | 15.6M | 18.0M | 18.9M | |
Interest Expense | 1.1M | 295K | 294K | 196K | 176.4K | 167.6K | |
Total Revenue | 139.7M | 277.0M | 383.5M | 493.6M | 567.7M | 596.1M | |
Gross Profit | 126.6M | 252.2M | 339.0M | 434.6M | 499.7M | 524.7M | |
Operating Income | 18.4M | 6.7M | (28.1M) | (14.0M) | (12.6M) | (12.0M) | |
Ebit | 14.9M | 11.0M | (25.9M) | 4.5M | 4.0M | 4.2M | |
Research Development | 18.4M | 51.0M | 74.2M | 87.5M | 100.7M | 105.7M | |
Ebitda | 16.4M | 15.5M | (18.3M) | 15.2M | 17.5M | 18.3M | |
Cost Of Revenue | 13.1M | 24.8M | 44.5M | 59.1M | 67.9M | 71.3M | |
Income Before Tax | 13.8M | 10.7M | (26.2M) | 4.2M | 3.8M | 4.0M | |
Net Income | 13.8M | 9.8M | (29.3M) | (1.6M) | (1.5M) | (1.5M) | |
Income Tax Expense | (912K) | 845K | 3.1M | 5.9M | 6.8M | 7.1M |
Inari Medical Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | (6.6M) | (10.5M) | (11.7M) | (7.4M) | (6.7M) | (7.0M) | |
Investments | (55.4M) | (37.4M) | (195.2M) | (58.0M) | (52.2M) | (54.8M) | |
Change In Cash | 90.6M | (21.9M) | (32.5M) | (21.0M) | (18.9M) | (18.0M) | |
Free Cash Flow | (3.5M) | 11.8M | (23.9M) | 29.7M | 34.2M | 35.9M | |
Depreciation | 1.4M | 4.3M | 7.1M | 10.7M | 12.3M | 13.0M | |
Other Non Cash Items | 181K | 143K | 973K | (15.6M) | (14.0M) | (13.3M) | |
Capital Expenditures | 5.5M | 13.6M | 10.0M | 6.2M | 7.1M | 7.2M | |
Net Income | 13.8M | 9.8M | (29.3M) | (1.6M) | (1.5M) | (1.5M) | |
End Period Cash Flow | 114.6M | 92.8M | 60.2M | 39.2M | 45.1M | 64.7M | |
Change To Netincome | 1.9M | 7.7M | 25.5M | 29.5M | 33.9M | 35.6M |
Inari Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inari Medical's current stock value. Our valuation model uses many indicators to compare Inari Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inari Medical competition to find correlations between indicators driving Inari Medical's intrinsic value. More Info.Inari Medical is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers . As of now, Inari Medical's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inari Medical's earnings, one of the primary drivers of an investment's value.Inari Medical's Earnings Breakdown by Geography
Inari Medical Systematic Risk
Inari Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Inari Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Inari Medical correlated with the market. If Beta is less than 0 Inari Medical generally moves in the opposite direction as compared to the market. If Inari Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Inari Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Inari Medical is generally in the same direction as the market. If Beta > 1 Inari Medical moves generally in the same direction as, but more than the movement of the benchmark.
Inari Medical Thematic Clasifications
Inari Medical is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Medical Equipment | View |
Today, most investors in Inari Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Inari Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Inari Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Inari Medical January 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Inari Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Inari Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Inari Medical based on widely used predictive technical indicators. In general, we focus on analyzing Inari Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Inari Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 2.12 | |||
Information Ratio | 0.1946 | |||
Maximum Drawdown | 30.79 | |||
Value At Risk | (3.87) | |||
Potential Upside | 6.43 |
Complementary Tools for Inari Stock analysis
When running Inari Medical's price analysis, check to measure Inari Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inari Medical is operating at the current time. Most of Inari Medical's value examination focuses on studying past and present price action to predict the probability of Inari Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inari Medical's price. Additionally, you may evaluate how the addition of Inari Medical to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |